The oncogenic capabilities of MYC to impinge on several hallmarks of cancer, such as proliferation, modulation of the tumor microenvironment, and migration, have been well known for a few decades3 and have made MYC a prime target in oncology. The gene discussed is MYC; the disease is cancer.